Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript August 8, 2024

Iovance Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.34092, expectations were $-0.37.

Operator: Welcome to the Iovance Biotherapeutics Conference Call to discuss Second Quarter 2024 Results and Recent Corporate Updates. My name is Daniel and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a...